Profiel
Jayakrishna Ambati is the founder of Inflammasome Therapeutics, Inc. which was founded in 2016, where he holds the title of Director.
He is currently working as Director & VP-Advanced Ocular Design at iVeena Delivery Systems, Inc.
Actieve functies van Jayakrishna Ambati
Bedrijven | Functie | Begin |
---|---|---|
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Directeur/Bestuurslid | - |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Oprichter | 01-01-2016 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |